This document summarizes a study on perinatal depression in Nigeria. The study aims to improve detection and treatment of perinatal depression through training primary care providers. So far, the study has recruited over 2000 women and found a perinatal depression rate of 7-19%. The study is conducting interviews and assessments of primary care clinics. Challenges include low detection rates, lack of private screening spaces, and difficulties locating patients. The study is engaging with health officials and building capacity. Next steps include finalizing training materials and training trainers to scale the intervention. A related proposed study would adapt interventions for adolescent mothers, who are a high-risk group.
1 of 4: Reducing Neonatal Mortality - Prevention, Early Detection and Treatme...JSI
This presentation by JSI's Leela Khanal, "Better Cord Care Saves Babies' Lives" was part of a dynamic panel moderated by JSI's Dr. Penny Dawson on February 13, 2015 at the 14th World Congress on Public Health in Kolkata, India. Four speakers summarized evidence for interventions proven to reduce newborn mortality (e.g., chlorhexidine) and shared important policy and programmatic experiences in prevention and treatment of neonatal infections. JSI's Leela Khanal and Dr. Nosa Orobaton spoke about experiences from Nepal and Nigeria in scaling up chlorhexidine use in those countries. Another speaker shared results from the COMBINE trial in Ethiopia, implemented primarily by JSI with support from SAVE/SNL, which evaluated the impact on neonatal mortality of health extension worker-led management of bacterial infections.
1 of 4: Reducing Neonatal Mortality - Prevention, Early Detection and Treatme...JSI
This presentation by JSI's Leela Khanal, "Better Cord Care Saves Babies' Lives" was part of a dynamic panel moderated by JSI's Dr. Penny Dawson on February 13, 2015 at the 14th World Congress on Public Health in Kolkata, India. Four speakers summarized evidence for interventions proven to reduce newborn mortality (e.g., chlorhexidine) and shared important policy and programmatic experiences in prevention and treatment of neonatal infections. JSI's Leela Khanal and Dr. Nosa Orobaton spoke about experiences from Nepal and Nigeria in scaling up chlorhexidine use in those countries. Another speaker shared results from the COMBINE trial in Ethiopia, implemented primarily by JSI with support from SAVE/SNL, which evaluated the impact on neonatal mortality of health extension worker-led management of bacterial infections.
Data and evidence to address India's nutrition challenge: POSHAN's State Poli...POSHAN
Presented at 'Strengthening National, State and District-level Actions for Nutrition: Insights from the National Family Health Survey Data' on 13th December, 2017 at IIC, New Delhi.
Visit the POSHAN website for more: www.poshan.ifpri.info
Data and evidence to address India's nutrition challenge: POSHAN's State Poli...POSHAN
Presented at 'Strengthening National, State and District-level Actions for Nutrition: Insights from the National Family Health Survey Data' on 13th December, 2017 at IIC, New Delhi.
Visit the POSHAN website for more: www.poshan.ifpri.info
Practicum presentation on Safe Motherhood Program (SMP) and Maternal and Peri...Mohammad Aslam Shaiekh
Practicum presentation on Safe Motherhood Program (SMP) and Maternal and Perinatal Death Surveillance and Response (MPDSR) Program in MNH Section of Family Welfare Division..
Improving Childhood Development in HIV Exposed Children in ZimbabweWorldEd
Despite an increasing recognition of the importance of early childhood development, over 200 million children in developing countries are unable to achieve their full developmental potential.
To intervene at this important juncture in a child’s life, the Bantwana Initiative of World Education (Bantwana) is implementing an Early Childhood Stimulation (ECS) program in Zimbabwe, a community-based early childhood development intervention in pediatric HIV care and treatment program. The intervention includes three elements: 1) an early childhood stimulation parenting program, 2) an internal savings and lending scheme for caregivers, and 3) case management home visits by conducted by trained community case workers. This comprehensive, community-based program aims to improve early childhood development, and HIV retention and adherence outcomes among HIV-exposed and infected children aged 0-2 years. Furthermore, it improves adherence and retention in care and treatment for the mothers of these HIV-exposed children, while equipping them with important parenting knowledge and skills to better nurture their children. These critical educational parenting sessions help increase early childhood development outcomes for HIV exposed children, as well as improve retention and adherence on HIV care and treatment for the mother-baby pairs. Together, the increased parenting skills, economic resilience, and community case worker follow up aim to improve the future of this particularly-vulnerable group of children, intervening at an essential point in their developmental growth.
This was presented by Auxilia Badza at the CIES conference in March, 2018.
Innovations in Breastfeeding and Breastmilk Feeding in the NICULeith Greenslade
Can "Lactation Scorecards" drive up low rates of breastmilk feeding in NICUs? Low rates of breastfeeding and breastmilk feeding among sick and vulnerable newborns contribute to low survival rates and poor development outcomes. Medela has developed a new tool that enables NICUs to set new targets and measure their performance - The NICU Lactation Care Scorecard.
Presentation by Jeff Sanderson at "Post-Ebola Survivors - Research and Recovery Lessons from West Africa," a USAID Brown Bag on May 2, 2019 at USAID/Crystal City.
Together with NIH/PREVAIL, today’s session focuses on learnings from these programs in relation to survivor care and post-outbreak recovery of health services and health systems.
Facilitator: Jeff Sanderson, Team Leader, West Africa Post-Ebola Programs, JSI R&T/APC
The Presenters:
Dr. Libby Higgs, Global Health Science Advisor for the Division of Clinical Research at NIAID, NIH (confirmed)
Dr. Meba Kagone, former Chief of Party for ETP&SS, Guinea, JSI/APC (confirmed)
Dr. Rose Macauley, former Chief of Party for ETP&SS, Liberia, JSI/APC (confirmed)
Jeff Sanderson (for Dr. Kwame Oneill, former Director of the Program Implementation Unit, Ministry of Health and Sanitation, Sierra Leone)
Background:
The Ebola Transmission Prevention & Survivor Services (ETP&SS) program included four components; country programs in Guinea, Liberia and Sierra Leone, and a regional program designed to share best practices and lessons learned.
ETP&SS assisted these governments to prevent further Ebola transmission, reduce stigma and other barriers to care for survivors when accessing health services, support the strengthening of needed specialty services, and build more resilient and self-sustaining health systems.
The regional program sought to ensure the sharing of lessons learned and best practices across the three countries and the region through meetings, exchanges and conferences with partners such as NIH, WHO, and the West African Consortium.
Funded by the Global Health Bureau through the Advancing Partners & Communities Project, John Snow Research & Training Institute implemented the program from July 2016 through July/August 2018.
2021-2022 NTTAP Webinar: Building the Case for Implementing Postgraduate NP R...CHC Connecticut
Join us as we discuss the drivers and processes of implementing a postgraduate nurse practitioner residency program at your health center, the benefits of implementing a postgraduate residency program, and the residency tracks for Family, Psychiatric/Mental Health, Pediatric, and Adult-Gerontology Nurse Practitioners.
We will be joined by Charise Corsino, Program Director of the Nurse Practitioner Residency Program, and Nicole Seagriff, Clinical Program Director of the Primary Care Nurse Practitioner Residency Program, from the Community Health Center Inc.
Practicum presentation on Safe Motherhood Program (SMP) and Maternal and Peri...Mohammad Aslam Shaiekh
Practicum presentation on Safe Motherhood Program (SMP) and Maternal and Perinatal Death Surveillance and Response (MPDSR) Program in MNH Section of Family Welfare Division
Similar to Day 2 panel 3 scaling up care for perinatal depression ng 108040 (20)
The dimensions of healthcare quality refer to various attributes or aspects that define the standard of healthcare services. These dimensions are used to evaluate, measure, and improve the quality of care provided to patients. A comprehensive understanding of these dimensions ensures that healthcare systems can address various aspects of patient care effectively and holistically. Dimensions of Healthcare Quality and Performance of care include the following; Appropriateness, Availability, Competence, Continuity, Effectiveness, Efficiency, Efficacy, Prevention, Respect and Care, Safety as well as Timeliness.
ICH Guidelines for Pharmacovigilance.pdfNEHA GUPTA
The "ICH Guidelines for Pharmacovigilance" PDF provides a comprehensive overview of the International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH) guidelines related to pharmacovigilance. These guidelines aim to ensure that drugs are safe and effective for patients by monitoring and assessing adverse effects, ensuring proper reporting systems, and improving risk management practices. The document is essential for professionals in the pharmaceutical industry, regulatory authorities, and healthcare providers, offering detailed procedures and standards for pharmacovigilance activities to enhance drug safety and protect public health.
CHAPTER 1 SEMESTER V - ROLE OF PEADIATRIC NURSE.pdfSachin Sharma
Pediatric nurses play a vital role in the health and well-being of children. Their responsibilities are wide-ranging, and their objectives can be categorized into several key areas:
1. Direct Patient Care:
Objective: Provide comprehensive and compassionate care to infants, children, and adolescents in various healthcare settings (hospitals, clinics, etc.).
This includes tasks like:
Monitoring vital signs and physical condition.
Administering medications and treatments.
Performing procedures as directed by doctors.
Assisting with daily living activities (bathing, feeding).
Providing emotional support and pain management.
2. Health Promotion and Education:
Objective: Promote healthy behaviors and educate children, families, and communities about preventive healthcare.
This includes tasks like:
Administering vaccinations.
Providing education on nutrition, hygiene, and development.
Offering breastfeeding and childbirth support.
Counseling families on safety and injury prevention.
3. Collaboration and Advocacy:
Objective: Collaborate effectively with doctors, social workers, therapists, and other healthcare professionals to ensure coordinated care for children.
Objective: Advocate for the rights and best interests of their patients, especially when children cannot speak for themselves.
This includes tasks like:
Communicating effectively with healthcare teams.
Identifying and addressing potential risks to child welfare.
Educating families about their child's condition and treatment options.
4. Professional Development and Research:
Objective: Stay up-to-date on the latest advancements in pediatric healthcare through continuing education and research.
Objective: Contribute to improving the quality of care for children by participating in research initiatives.
This includes tasks like:
Attending workshops and conferences on pediatric nursing.
Participating in clinical trials related to child health.
Implementing evidence-based practices into their daily routines.
By fulfilling these objectives, pediatric nurses play a crucial role in ensuring the optimal health and well-being of children throughout all stages of their development.
Antibiotic Stewardship by Anushri Srivastava.pptxAnushriSrivastav
Stewardship is the act of taking good care of something.
Antimicrobial stewardship is a coordinated program that promotes the appropriate use of antimicrobials (including antibiotics), improves patient outcomes, reduces microbial resistance, and decreases the spread of infections caused by multidrug-resistant organisms.
WHO launched the Global Antimicrobial Resistance and Use Surveillance System (GLASS) in 2015 to fill knowledge gaps and inform strategies at all levels.
ACCORDING TO apic.org,
Antimicrobial stewardship is a coordinated program that promotes the appropriate use of antimicrobials (including antibiotics), improves patient outcomes, reduces microbial resistance, and decreases the spread of infections caused by multidrug-resistant organisms.
ACCORDING TO pewtrusts.org,
Antibiotic stewardship refers to efforts in doctors’ offices, hospitals, long term care facilities, and other health care settings to ensure that antibiotics are used only when necessary and appropriate
According to WHO,
Antimicrobial stewardship is a systematic approach to educate and support health care professionals to follow evidence-based guidelines for prescribing and administering antimicrobials
In 1996, John McGowan and Dale Gerding first applied the term antimicrobial stewardship, where they suggested a causal association between antimicrobial agent use and resistance. They also focused on the urgency of large-scale controlled trials of antimicrobial-use regulation employing sophisticated epidemiologic methods, molecular typing, and precise resistance mechanism analysis.
Antimicrobial Stewardship(AMS) refers to the optimal selection, dosing, and duration of antimicrobial treatment resulting in the best clinical outcome with minimal side effects to the patients and minimal impact on subsequent resistance.
According to the 2019 report, in the US, more than 2.8 million antibiotic-resistant infections occur each year, and more than 35000 people die. In addition to this, it also mentioned that 223,900 cases of Clostridoides difficile occurred in 2017, of which 12800 people died. The report did not include viruses or parasites
VISION
Being proactive
Supporting optimal animal and human health
Exploring ways to reduce overall use of antimicrobials
Using the drugs that prevent and treat disease by killing microscopic organisms in a responsible way
GOAL
to prevent the generation and spread of antimicrobial resistance (AMR). Doing so will preserve the effectiveness of these drugs in animals and humans for years to come.
being to preserve human and animal health and the effectiveness of antimicrobial medications.
to implement a multidisciplinary approach in assembling a stewardship team to include an infectious disease physician, a clinical pharmacist with infectious diseases training, infection preventionist, and a close collaboration with the staff in the clinical microbiology laboratory
to prevent antimicrobial overuse, misuse and abuse.
to minimize the developme
Global launch of the Healthy Ageing and Prevention Index 2nd wave – alongside...ILC- UK
The Healthy Ageing and Prevention Index is an online tool created by ILC that ranks countries on six metrics including, life span, health span, work span, income, environmental performance, and happiness. The Index helps us understand how well countries have adapted to longevity and inform decision makers on what must be done to maximise the economic benefits that comes with living well for longer.
Alongside the 77th World Health Assembly in Geneva on 28 May 2024, we launched the second version of our Index, allowing us to track progress and give new insights into what needs to be done to keep populations healthier for longer.
The speakers included:
Professor Orazio Schillaci, Minister of Health, Italy
Dr Hans Groth, Chairman of the Board, World Demographic & Ageing Forum
Professor Ilona Kickbusch, Founder and Chair, Global Health Centre, Geneva Graduate Institute and co-chair, World Health Summit Council
Dr Natasha Azzopardi Muscat, Director, Country Health Policies and Systems Division, World Health Organisation EURO
Dr Marta Lomazzi, Executive Manager, World Federation of Public Health Associations
Dr Shyam Bishen, Head, Centre for Health and Healthcare and Member of the Executive Committee, World Economic Forum
Dr Karin Tegmark Wisell, Director General, Public Health Agency of Sweden
Deep Leg Vein Thrombosis (DVT): Meaning, Causes, Symptoms, Treatment, and Mor...The Lifesciences Magazine
Deep Leg Vein Thrombosis occurs when a blood clot forms in one or more of the deep veins in the legs. These clots can impede blood flow, leading to severe complications.
Navigating Challenges: Mental Health, Legislation, and the Prison System in B...Guillermo Rivera
This conference will delve into the intricate intersections between mental health, legal frameworks, and the prison system in Bolivia. It aims to provide a comprehensive overview of the current challenges faced by mental health professionals working within the legislative and correctional landscapes. Topics of discussion will include the prevalence and impact of mental health issues among the incarcerated population, the effectiveness of existing mental health policies and legislation, and potential reforms to enhance the mental health support system within prisons.
Leading the Way in Nephrology: Dr. David Greene's Work with Stem Cells for Ki...Dr. David Greene Arizona
As we watch Dr. Greene's continued efforts and research in Arizona, it's clear that stem cell therapy holds a promising key to unlocking new doors in the treatment of kidney disease. With each study and trial, we step closer to a world where kidney disease is no longer a life sentence but a treatable condition, thanks to pioneers like Dr. David Greene.
India Clinical Trials Market: Industry Size and Growth Trends [2030] Analyzed...Kumar Satyam
According to TechSci Research report, "India Clinical Trials Market- By Region, Competition, Forecast & Opportunities, 2030F," the India Clinical Trials Market was valued at USD 2.05 billion in 2024 and is projected to grow at a compound annual growth rate (CAGR) of 8.64% through 2030. The market is driven by a variety of factors, making India an attractive destination for pharmaceutical companies and researchers. India's vast and diverse patient population, cost-effective operational environment, and a large pool of skilled medical professionals contribute significantly to the market's growth. Additionally, increasing government support in streamlining regulations and the growing prevalence of lifestyle diseases further propel the clinical trials market.
Growing Prevalence of Lifestyle Diseases
The rising incidence of lifestyle diseases such as diabetes, cardiovascular diseases, and cancer is a major trend driving the clinical trials market in India. These conditions necessitate the development and testing of new treatment methods, creating a robust demand for clinical trials. The increasing burden of these diseases highlights the need for innovative therapies and underscores the importance of India as a key player in global clinical research.
India Clinical Trials Market: Industry Size and Growth Trends [2030] Analyzed...
Day 2 panel 3 scaling up care for perinatal depression ng 108040
1. Scaling up care for perinatal depression for
improved maternal and infant health (SPECTRA)
Synergy Proposal: Responding to the challenge of
adolescent perinatal depression (RAPID)
The IRT: Prof Oye Gureje-PI; Co-PIs: Prof Phyllis Zelkowitz (Canada),
Dr Kayode Ogunniyi (Policy Maker); Co-Is: Dr Lola Kola- Co-I
(Project Coordinator), Dr Bibilola Oladeji, Dr Neda Faregh, Dr Jibril
Abdulmalik, Dr Bidemi Yusuf, Dr Saheed Olayiwola
2. Background
• Depression is a leading cause of disease burden worldwide,
• In LMIC, perinatal depression occur in between 16% and 20% of women
• Perinatal depression is associated with negative outcomes for both the mother
and their children
• Early identification and prompt interventions known to reduce these negative
consequences
• The interventions needed not necessarily specialist care
• Evidence based interventions delivered by supervised, non-specialist health and
community workers in primary care shown to be beneficial to both the mothers
and their infants
3. Overall Aim
• The overall aim of this program is to study factors that may impede or
facilitate the delivery of evidence-based intervention for perinatal
depression by front-line clinicians using the WHO Mental Health Gap
Action Programme Intervention Guide (mhGAP-IG) in routine practice.
• The knowledge so gained, including that gained in the process of
responding to barriers that may be encountered, will provide
necessary information to facilitate the scaling up of the intervention in
other parts of Nigeria and other resource-constrained settings.
4. Methods
In this implementation study we are using a mixed methods design, with a
participatory approach adopted at every stage. The study is being conducted in 20
selected primary care clinics selected across 10 local government areas in Oyo
State, south-west Nigeria
There are 4 overlapping phases
1. Formative evaluation and concept development
2. Assessment of the organizational structure and clinic profile of the primary
maternal and child care clinics and determination of current rate of detection
and treatment for perinatal depression
3. Design and implementation of training of primary care providers to provide
care for perinatal depression to achieve sustainable impact
4. Evaluating the effectiveness of the mhGAP-IG and evaluating the gaps and
bottlenecks in the provision of care
5. Results to date
We are currently implementing Phases 1 and 2
• We had a planning workshop at the commencement of the study in 2015, to
design an implementation plan for the study. The outcome of this was the
development a theory of change (TOC) map for the study.
• There have been 2 consultative workshops with the health planners in
collaboration with Directorate of Planning, Research and Statistics of the Oyo
State Ministry of Health held in May and July 2016
• We have collected data on the organizational structure in relation to providing
chronic care for the 24 primary maternal clinics selected for the study using the
Assessment of Chronic Illness Care (ACIC) tool
• We have conducted key informant interviews with 20 facility managers to assess
the needs of the providers, current levels of training, and infrastructural and
organizational needs for the delivery of quality care
6.
7. Results to date
• We have recruited and trained
research staff
• Investigators meetings hold as
scheduled
• The first draft of the training
manual for use in phase 3 of our
implementation is completed
8. Results to date
• Recruitment of the first cohort of
patients to be used to determine
the current facility detection
rates and the interventions
provided for perinatal depression
is ongoing
• Screened:2970
• Positive: 216
• Recruited: 202
• Follow-up assessments
• 2 months post enrollment: 164
• 3 months post partum: 68 out
of 74 due for assessment
9. Key Lessons Learned
• Mental health is not captured in the current health
information routine data collection system.
• Detection of perinatal depression by primary maternal health
care workers is very low
• Mothers are hardly routinely asked questions about their
mental health
10. Policy Engagement Meetings
• Meeting with the Executive
Secretary of the State Primary
Care Board, February 2017
• MOU drafted and currently in the
process of being endorsed
• Meeting with the Honorable
Commissioner for Health, with
some of the most senior
officials of the Oyo State
Ministry of Health
• Commitment for the creation of a
mental health desk and appoint a
desk officer
11. Challenges and mitigation strategies
• There was an industrial action in the Oyo State Civil Service that lasted
10 weeks from May 9, 2016 which delayed the onset of recruitment of
participants
• Patient turn out in the primary care clinics for antenatal registration
was initially lower than anticipated
• Things later picked up and we were able to surpass the recruitment target for
Cohort One
• In some clinics we had some difficulty in getting a private space for
patient screening
• We had to provide some facilities such as furniture in some clinics to enable
research staff conduct screening and ensure the privacy of the participants
12. Challenges and mitigation strategies
• Locating the homes of some patients from the addresses
provided to the research staff is sometimes difficult
• Research assistants are trained to document not just house numbers but
description of houses with identifiable landmarks, also mobile phone numbers
provided by the participants during recruitment have been helpful
• Conduct of the key informant interviews was also slower
than anticipated due to the busy work schedule of the
clinicians
• Appointments were often scheduled for interviews outside of busy working
hours of the clinicians. We have now completed planned number of
interviews
13. Capacity Strengthening
• Working with the ministry and the Director of Planning to draft the
terms of reference for the Mental Health Desk Officer
• The project will sponsor the appointed officer to attend the 2-week
annual mental health leadership and advocacy course conducted by
the WHO Collaborating Center for Research and Training, Department
of Psychiatry, University of Ibadan
• We are using a cascade training format, to build a pool of trainers
within the primary care health force that can be used to sustain
training and delivery of mental health
• An implementation science workshop to build capacity in the conduct
of implementation research in maternal health is planned before the
end of the year
14. Next Steps and areas for collaboration
• We will continue to work with the HPRO especially to
facilitate policy uptake both at the Federal and State levels
• We will continue to engage with the National Mental Health
Action Committee
• The training manuals and other training materials as well as
the intervention guides will be completed over the next
month
• Training of the trainers is scheduled for the end of May
• Training of frontline providers by the trained trainers will
commence thereafter
15. Synergy Proposal (RAPID): Background
• Adolescent pregnancy is a pressing public health issue globally
• In Nigeria, for example, about 31% of women have had a live birth
before age 18
• Reported prevalence of perinatal depression in adolescents range
from 8% to 47% often higher than for older women
• In our earlier study, we observed a prevalence of 18.8% in adolescents
(mean age 17.8 years) compared to 6.9% in those aged ≥20 years
• Adolescent perinatal depression is associated with unique
consequences such as increased risk of further pregnancy and
problems with parenting and negative outcomes on their children
16. Background
• Adolescents with perinatal depression compared to adults
• exhibit poorer adjustment to pregnancy and to motherhood
• higher rates of pre-term birth and low birth weight
• use of aggressive parenting behaviors
• growth stunting and cognitive delays in young children
• preschool problem behavior, poorer school performance, and higher levels of
psychopathology in their children at 14 years of age
• They are less likely to receive any form of care for depression
• When they do, they are more likely to be poorly adherent
• Adolescents with depression hence require targeted interventions to
keep them engaged and adherent to treatment and enhance
parenting skills for improved infant and child outcomes
17. RAPID: Research Questions and Objectives
• RAPID is designed to fill an important gap in knowledge about how
best to respond to the needs of this vulnerable but previously
neglected population of women with perinatal depression. We will be
comparing 2 evidence based intervention packages for perinatal
depression to answer the following questions:
1. What are the contextual factors that affect the detection of
perinatal depression in adolescents and the delivery of interventions
with proven effectiveness for the condition within a routine
integrated primary maternal care service
2. When delivered within routine and integrated maternal and child
care, what is the impact of the intervention on maternal depression
outcome, user satisfaction, parenting skills and on infant
development
18. RAPID: Methods
• The study will be conducted in the same primary care clinics where
our primary implementation study is being conducted in Oyo State
• This will be a hybrid Type I (effectiveness – implementation) study
guided by the Consolidated Framework for Implementation Research
(CFIR) framework
• The study will use a mix of qualitative and quantitative methods and
involve all relevant stakeholders from planning, through execution to
ensure the likelihood of policy uptake
19. Methods
• Use of KIIs to explore the contextual issues surrounding the provision
and receipt of care by adolescents with perinatal depression who
participated in our recently concluded RCT
• Sample (10 each): adolescents who completed required treatment
and follow-up, adolescents who dropped out of treatment, midwives
who provided care and facility managers of the clinics
• Planning workshop involving all stakeholders- some already engaged,
others will be brought on board; an external health system researcher
• Guided by the results from these initial activities, we will modify the
proposed process of intervention delivery
20. Proposed Procedure
• We shall be comparing 2 groups of
• One group shall be randomized to receive interventions for
depression only (using our manual based on the WHO mhGAP-IG
• The other will receive this same intervention in addition to parenting
skills and more engagement with the primary care providers over the
mobile phone
• Patients will be screened with EPDS and complete an encounter form
after being seen by the primary care provider
• We shall aim to recruit 320 participants with moderate to severe
depression at registration for ANC and follow them up till 1 year
postpartum to collect effectiveness and implementation outcomes
21. Areas for Strategic Consideration/Collaboration
• This study will build on our existing engagement and collaborations
with policy makers and other stakeholders
• Within the Oyo State Ministry of Health,
• The State’s Primary Health Care Development Board (with which
we currently are developing a Memorandum of Understanding),
• The National Primary Health Care Development Agency
• The National Mental Health Action Committee
• Midwives and physicians working at the primary care clinics
The team is bringing on board other experts including an
obstetrician, implementation scientist with expertise in perinatal
mental health and